[Experimental studies of anthelmintics. 21. Pharmacological studies of 1-(2-(dodecyloxy)ethyl) pyrrolidine hydrochloride (DEP) on ascaris lumbricoidessuum].
D000109:Acetylcholine / Q000037:antagonists & inhibitors / Q000494:pharmacology; D000473:Alkanes / Q000378:metabolism / Q000494:pharmacology; D000818:Animals; D000871:Anthelmintics / Q000378:metabolism / Q000494:pharmacology*; D001200:Ascaris / Q000187:drug effects* / Q000378:metabolism; D001285:Atropine / Q000494:pharmacology; D002118:Calcium / Q000378:metabolism; D003470:Culture Media; D004987:Ethers / Q000378:metabolism / Q000494:pharmacology; D006863:Hydrogen-Ion Concentration; D009119:Muscle Contraction / Q000187:drug effects; D010208:Papaverine / Q000494:pharmacology; D011343:Procaine / Q000494:pharmacology; D011759:Pyrrolidines / Q000378:metabolism / Q000494:pharmacology*; D013331:Strychnine / Q000494:pharmacology; D013552:Swine; D014403:Tubocurarine / Q000494:pharmacology
D000473:Alkanes; D000871:Anthelmintics; D003470:Culture Media; D004987:Ethers; D011759:Pyrrolidines; C007268:1-(2-(dodecyloxy)ethyl)pyrrolidine hydrochloride; D011343:Procaine; D001285:Atropine; D010208:Papaverine; D013331:Strychnine; D000109:Acetylcholine; D002118:Calcium; D014403:Tubocurarine